EMN
Eastman Chemical Company
NYSE · Basic Materials · Chemicals - Specialty · US
$70.75
−0.03%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 8.9B | 8.8B | 9.4B | 9.2B | 10.5B |
| Cost of Revenue | 7.1B | 6.9B | 7.1B | 7.1B | 8.5B |
| Gross Profit | 1.8B | 1.8B | 2.3B | 2.1B | 2.1B |
| Operating Expenses | |||||
| R&D Expense | 246.0M | 255.0M | 250.0M | 239.0M | 264.0M |
| SG&A Expense | 682.0M | 658.0M | 664.0M | 727.0M | 708.0M |
| General & Admin Expense | — | — | 664.0M | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 928.0M | 913.0M | 914.0M | 966.0M | 972.0M |
| Cost and Expenses | 8.0B | 7.8B | 8.0B | 8.1B | 9.5B |
| Operating Income (EBIT) | 834.0M | 931.0M | 1.4B | 1.1B | 1.1B |
| Non-Operating | |||||
| Interest Income | 6.0M | — | 16.0M | 10.0M | 6.0M |
| Interest Expense | 213.0M | 208.0M | 216.0M | 225.0M | 188.0M |
| Net Interest Income | (207.0M) | (208.0M) | (200.0M) | (215.0M) | (182.0M) |
| Other Non-Op Income/Expense | (296.0M) | (363.0M) | (298.0M) | (9.0M) | (107.0M) |
| Non-Operating Income (excl Interest) | 85.0M | 155.0M | 82.0M | (213.0M) | (75.0M) |
| EBT (Pre-Tax Income) | 538.0M | 568.0M | 1.1B | 1.1B | 977.0M |
| Income Tax Expense | 95.0M | 93.0M | 170.0M | 191.0M | 181.0M |
| Bottom Line | |||||
| Net Income | 442.0M | 474.0M | 905.0M | 894.0M | 793.0M |
| Earnings from Cont. Ops | 443.0M | 475.0M | 908.0M | 896.0M | 796.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 442.0M | 474.0M | 905.0M | 894.0M | 793.0M |
| Per Share | |||||
| Basic EPS | $3.87 | $4.13 | $7.75 | $7.54 | $6.42 |
| Diluted EPS | $3.85 | $4.10 | $7.67 | $7.49 | $6.35 |
| Revenue Per Share | $77.56 | $76.30 | $80.39 | $77.55 | $85.30 |
| Shares | |||||
| Basic Shares Outstanding | 114.3M | 114.7M | 116.7M | 118.6M | 123.5M |
| Diluted Shares Outstanding | 115.3M | 115.6M | 117.9M | 119.4M | 124.9M |
| Profitability Metrics | |||||
| EBITDA | 1.3B | 1.3B | 1.8B | 1.8B | 1.6B |
| D&A | 523.0M | 513.0M | 509.0M | 498.0M | 477.0M |
| EBIT | 749.0M | 776.0M | 1.3B | 1.3B | 1.2B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026